THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

PEREGRINE CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000764529)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021

Shares 459,716 Value ($000) $6,675 Avg Close $18.78 Range $14.46 - $22.74

Q1 2021

Shares 484,206 Value ($000) $9,883 Avg Close $19.01 Range $16.46 - $21.21

Q4 2020

Shares 551,830 Value ($000) $9,806 Avg Close $17.95 Range $14.48 - $20.53

Q3 2020

Shares 412,594 Value ($000) $6,100 Avg Close $18.73 Range $14.62 - $22.82

Q2 2020

Shares 451,955 Value ($000) $9,487 Avg Close $25.69 Range $20.17 - $31.35

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2021	459,716	$6,675	$18.78	$14.46 - $22.74
Q1 2021	484,206	$9,883	$19.01	$16.46 - $21.21
Q4 2020	551,830	$9,806	$17.95	$14.48 - $20.53
Q3 2020	412,594	$6,100	$18.73	$14.62 - $22.82
Q2 2020	451,955	$9,487	$25.69	$20.17 - $31.35